45 is the New 50: Demographic Trends in Colorectal Cancer Drive Recent US Screening Guideline Changes Emily HuangMatthew F. Kalady Aso Perspectives 19 January 2023 Pages: 1927 - 1929
Practice-Changing Evidence in Surgical Oncology: An Annals of Surgical Oncology Series Timothy M. PawlikKelly M. McMasters Global Health Services Research 21 January 2023 Pages: 1930 - 1931
Do Lymph Nodes Matter in Intrahepatic Cholangiocarcinoma? Flavio G. Rocha Hepatobiliary Tumors 10 January 2023 Pages: 1932 - 1934
It is not “If” but “How” Preoperative Frailty Assessment Should be Provided Beatriz Korc-Grodzicki Colorectal Cancer 30 December 2022 Pages: 1935 - 1937
Invited Editorial on Breast Surgical Oncology Epidemiological Research: A Guide and Comparison of Four National Databases Angelena CrownKathie-Ann Joseph Global Health Services Research 13 December 2022 Pages: 1938 - 1939
Local Regional Recurrence Rates Are Low Following Neoadjuvant Endocrine Therapy: What Are the Remaining Barriers to its Widespread Adoption? Anna WeissTari A. King Breast Oncology 01 January 2023 Pages: 1940 - 1942
Optimizing Sentinel Node Biopsy After Neoadjuvant Therapy: Striving to Know What We Do Not Know Steven G. WoodwardOluwadamilola M. Fayanju Breast Oncology 20 January 2023 Pages: 1943 - 1944
Nomogram for Predicting Pathologic Response Following Neoadjuvant Chemotherapy or Chemoradiotherapy in Patients with Esophageal Cancer Ulysses Ribeiro Jr. Thoracic Oncology 30 January 2023 Pages: 1945 - 1947
Intensive Surveillance After Esophagectomy in Patients with Esophageal Cancer: When, Why, and How Often? Jan Willem Haveman Thoracic Oncology 13 November 2022 Pages: 1948 - 1949
Primary Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) (OVHIPEC-2) Stephanie N. GregoryCarrie E. Ryanthe OVHIPEC-2 Study Group Aso Research Letter 29 December 2022 Pages: 1950 - 1952
Texture Analysis Identifies Distinct Radiomic Signals Associated with Survival in Hispanic Patients with Pancreatic Cancer Francesco AlessandrinoEtienne C. GozlanJashodeep Datta Aso Research Letter 29 December 2022 Pages: 1953 - 1955
Outcomes of Single Node Excision Compared with Lymph Node Dissection for Patients with Clinical Stage III N1b Cutaneous Melanoma Cimarron E. SharonGabriella N. TortorelloGiorgos C. Karakousis Aso Research Letter 16 January 2023 Pages: 1956 - 1959
Practice-Changing Evidence in Surgical Oncology 2021: Hepatobiliary Articles Alice C. Wei Hepatobiliary Tumors 06 February 2023 Pages: 1960 - 1965
Predictors, Patterns, and Impact of Adequate Lymphadenectomy in Intrahepatic Cholangiocarcinoma Zorays MoazzamLaura AlaimoTimothy M. Pawlik Hepatobiliary Tumors 09 January 2023 Pages: 1966 - 1977
ASO Author Reflections: Lymphadenectomy for Intrahepatic Cholangiocarcinoma–Predictors, Patterns, and Prognostic Impact Zorays MoazzamLaura AlaimoTimothy M. Pawlik Aso Author Reflections 08 January 2023 Pages: 1978 - 1979
ASO Visual Abstract: Predictors, Patterns, and Impact of Adequate Lymphadenectomy in Intrahepatic Cholangiocarcinoma Zorays MoazzamLaura AlaimoTimothy M. Pawlik ASO Visual Abstract 31 January 2023 Pages: 1980 - 1980
Does Using Indocyanine Green Fluorescence Imaging for Tumors Help in Determining the Safe Surgical Margin in Real-Time Navigation of Laparoscopic Hepatectomy? A Retrospective Study Xinran CaiHaijie HongYanling Chen Hepatobiliary Tumors Open access 09 December 2022 Pages: 1981 - 1987
ASO Author Reflections: The Application of ICG Fluorescent Staining in Laparoscopic Hepatectomy for Liver Malignancies is More Beneficial to Ensure Radical Surgery Xinran CaiHaijie HongYanling Chen Aso Author Reflections 17 December 2022 Pages: 1988 - 1989
ASO Visual Abstract: Whether Using Indocyanine Green Fluorescence Imaging for Tumor Helps Determining Safe Surgical Margin in Real-Time Navigation of Laparoscopic Hepatectomy? A Retrospective Study Xinran CaiHaijie HongYanling Chen Aso Visual Abstract 05 January 2023 Pages: 1990 - 1990
Short- and Long-Term Outcomes of Indocyanine Green Fluorescence Navigation- Versus Conventional-Laparoscopic Hepatectomy for Hepatocellular Carcinoma: A Propensity Score-Matched, Retrospective, Cohort Study Fusheng LiuHaitao WangYufeng Yuan Hepatobiliary Tumors Open access 16 January 2023 Pages: 1991 - 2002
ASO Author Reflections: Indocyanine Green Fluorescence Navigation in Liver Surgery: Current Applications and Future Perspectives Fusheng LiuYufeng Yuan ASO Author Reflections Open access 13 January 2023 Pages: 2003 - 2004
ASO Visual Abstract: Short- and Long-Term Outcomes of Indocyanine Green Fluorescence Navigation Versus Conventional Laparoscopic Hepatectomy for Hepatocellular Carcinoma—A Propensity Score-Matched Retrospective Cohort Study Fusheng LiuHaitao WangYufeng Yuan ASO Visual Abstract 08 February 2023 Pages: 2005 - 2006
An Integrated Liver Function, Systemic Inflammation, and Tumor Characteristic Score Predicts Prognosis in Hepatocellular Carcinoma After Curative Resection Yao TongJun-Xiang LiYu-Dong Xiao Hepatobiliary Tumors 29 December 2022 Pages: 2007 - 2020
ASO Author Reflections: The FIBA Score—A Novel Scoring System to Predict Outcomes in Hepatocellular Carcinoma After Surgical Resection or Transarterial Chemoembolization De-Hua ChangYu-Dong XiaoYao Tong Aso Author Reflections Open access 24 December 2022 Pages: 2021 - 2022
Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status on Overall Survival in Patients Undergoing Resection of Intrahepatic Cholangiocarcinoma Yutaka EndoKazunari SasakiTimothy M. Pawlik Hepatobiliary Tumors 17 November 2022 Pages: 2023 - 2032
ASO Author Reflections: Higher Tumor Burden Status Dictates the Impact of Surgical Margin Status in Patients with Intrahepatic Cholangiocarcinoma Yutaka EndoZorays MoazzamTimothy M. Pawlik ASO Author Reflections 17 November 2022 Pages: 2033 - 2034
High Risk, High Reward: Frailty in Colorectal Cancer Surgery is Associated with Worse Postoperative Outcomes but Equivalent Long-Term Oncologic Outcomes Eihab AbdelfatahVicente Ramos-SantillanGary Mann Colorectal Cancer 17 January 2023 Pages: 2035 - 2045
ASO Visual Abstract: High Risk, High Reward: Frailty in Colorectal Cancer Surgery Associates with Worse Postoperative Outcomes But Equivalent Long-Term Oncologic Outcomes Eihab AbdelfatahVicente Ramos-SantillanGary Mann ASO Visual Abstract 06 February 2023 Pages: 2046 - 2047
Treatment and Survival Outcomes for Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study Michelle V. DietzMerijn J. ZiekmanEva V. E. Madsen Colorectal Cancer 24 December 2022 Pages: 2048 - 2056
ASO Visual Abstract: Treatment and Survival Outcomes of Patients with Colorectal Peritoneal Metastases Deemed Ineligible for Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Results of a Retrospective Study Michelle V. DietzMerijn J. ZiekmanEva V. E. Madsen ASO Visual Abstract 31 January 2023 Pages: 2057 - 2057
Colonoscopy-Assisted Laparoscopic Wedge Resection for the Treatment of Suspected T1 Colon Cancer Julia HaneveltLeon M. G. MoonsHenderik L. van Westreenen Colorectal Cancer 04 January 2023 Pages: 2058 - 2065
ASO Author Reflections: Colonoscopic-Assisted Laparoscopic Wedge Resection Seems a Valuable Addition to the Current Local Resection Techniques in Case of Suspected Deep-Invasive T1 Colon Cancer Julia HaneveltLeon M. G. MoonsHenderik L. van Westreenen Aso Author Reflections 04 January 2023 Pages: 2066 - 2067
ASO Visual Abstract: Colonoscopy-Assisted Laparoscopic Wedge Resection for the Treatment of Suspected T1 Colon Cancer Julia HaneveltLeon M. G. MoonsHenderik L. van Westreenen ASO Visual Abstract 21 January 2023 Pages: 2068 - 2068
Breast Surgical Oncology Epidemiologic Research: A Guide and Comparison of Four National Databases Robyn N. RubensteinJonas A. NelsonEvan Matros Global Health Services Research 04 January 2023 Pages: 2069 - 2084
ASO Visual Abstract: Breast Surgical Oncology Epidemiologic Research—A Guide and Comparison of Four National Databases Robyn N. RubensteinJonas A. NelsonEvan Matros Aso Visual Abstract 31 January 2023 Pages: 2085 - 2086
Evaluation of the Impact of the COVID-19 Pandemic on Reliability of Cancer Surveillance Data in the National Cancer Database Leticia M. NogueiraBryan PalisHeidi Nelson Global Health Services Research 20 December 2022 Pages: 2087 - 2093
ASO Visual Abstract: Evaluation of the Impact of the COVID-19 Pandemic on Reliability of Cancer Surveillance Data in the National Cancer Database Leticia M. NogueiraBryan PalisHeidi Nelson Aso Visual Abstract 23 January 2023 Pages: 2094 - 2094
A New Method of Identifying Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer Patients Using a Population-Based Electronic Medical Record System Guosong WuCheligeer CheligeerYuan Xu Global Health Services Research 21 December 2022 Pages: 2095 - 2103
ASO Author Reflections: Development of Natural Language Processing-Based Machine-Learning Algorithms to Identify Pathologic Complete Response from Surgical Pathology Reports Guosong WuCheligeer CheligeerYuan Xu Aso Author Reflections 22 December 2022 Pages: 2104 - 2105
ASO Visual Abstract: A New Method of Identifying Pathologic Complete Response Following Neoadjuvant Chemotherapy for Breast Cancer Patients Using a Population-Based Electronic Medical Record System Guosong WuCheligeer CheligeerYuan Xu Aso Visual Abstract 16 January 2023 Pages: 2106 - 2107
COVID-19 Vaccination in Patients Who Develop COVID-19 following Cancer Surgery: Correspondence Rujittika MungmunpuntipantipViroj Wiwanitkit Global Health Services Research 10 January 2023 Pages: 2108 - 2108
Reply to: COVID-19 Vaccination in Patients who Develop COVID-19 After Cancer Surgery: Correspondence by Mungmunpuntipantip and Wiwanitkit Nathaniel B. VerhagenAnai N. Kothari Translational Research 27 January 2023 Pages: 2109 - 2110
Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer Kelly K. HuntVera J. SumanJohn Olson Breast Oncology 18 January 2023 Pages: 2111 - 2118
ASO Visual Abstract: Local-Regional Recurrence Following Neoadjuvant Endocrine Therapy – Data from ACOSOG Z1031 (Alliance), a Randomized Phase II Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor–Positive Clinical Stage 2–3 Breast Cancer Kelly K. HuntVera J. SumanJohn A. Olson ASO Visual Abstract 06 February 2023 Pages: 2119 - 2120
The Landmark Series: The Breast Cancer Burden of the Asian American Population and the Need for Disaggregated Data Claire M. EdenJosh JohnsonTammy Ju Breast Oncology 18 January 2023 Pages: 2121 - 2127
ASO Author Reflections: The Asian American Breast Cancer Population: Disaggregating the Monolith Claire M. EdenManmeet MalikTammy Ju ASO Author Reflections 03 February 2023 Pages: 2128 - 2129
Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer A. L. NashY. RenE. Shelley Hwang Breast Oncology 08 January 2023 Pages: 2130 - 2139
ASO Visual Abstract: Survival Benefit of Chemotherapy According to 21-Gene Recurrence Score in Young Women with Breast Cancer A. L. NashY. RenE. Shelley Hwang Aso Visual Abstract 25 January 2023 Pages: 2140 - 2141
Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model Claudia J. C. MeursJoost van RosmalenPieter J. Westenend Breast Oncology Open access 10 December 2022 Pages: 2142 - 2151
ASO Visual Abstract: Predicting Lymph Node Metastases in Patients with Biopsy-Proven Ductal Carcinoma In Situ of the Breast: Development and Validation of the DCIS-met Model Claudia J. C. MeursJoost van RosmalenPieter J. Westenend ASO Visual Abstract 25 January 2023 Pages: 2152 - 2153
